Transition Therapeutics (TTHI) Reports Q2 Loss of $0.17
Tweet
Share
E-mailGet Alerts TTHI Hot Sheet
Join SI Premium – FREE
Transition Therapeutics (NASDAQ: TTHI) reported Q2 EPS of ($0.17), versus ($0.05) reported last year.
For earnings history and earnings-related data on Transition Therapeutics (TTHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Stantec (STN) Tops Q2 EPS by 47c
- Marchex (MCHX) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
